Pharmacokinetic and pharmacodynamic properties of antimicrobials in the therapy of respiratory tract infections

被引:36
作者
Andes, D [1 ]
机构
[1] Univ Wisconsin, Sch Med, Dept Med, Infect Dis Sect, Madison, WI 53792 USA
关键词
D O I
10.1097/00001432-200104000-00010
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Antimicrobial pharmacodynamics examines the relationship between the pharmacokinetics of a drug over time and its treatment effect. Pharmacokinetic/pharmacodynamic parameters have been shown to be predictors of the antimicrobial activity of a variety of drugs. The pharmacodynamic parameter linked to efficacy has been demonstrated to vary for different antimicrobial classes. Within an antimicrobial class, the magnitude of the pharmacodynamic parameter predictive of efficacy has been shown to be similar, as long as free-drug levels in serum are considered. Treatment outcome predictions based upon parameter magnitudes have correlated well and have been useful for assessing the future course of both susceptible and resistant pathogens of the respiratory tract. This has been useful for the development of susceptibility breakpoints and antimicrobial treatment guidelines. Recent studies have begun to investigate the relationship between antimicrobial pharmacodynamics and the prevention of drug resistance. Curr Opin Infect Dis 14:165-172, (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:165 / 172
页数:8
相关论文
共 53 条
  • [1] AMBROSE PG, 2000, 40 INT C ANT AG CHEM
  • [2] In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae:: Application to breakpoint determinations
    Andes, D
    Craig, WA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) : 2375 - 2379
  • [3] ANDES D, 1998, 38 INT C ANT AG CHEM
  • [4] ANDES DR, 2000, 40 INT C ANT AG CHEM
  • [5] Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954
  • [6] Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci
    Betriu, C
    Redondo, M
    Palau, ML
    Sánchez, A
    Gómez, M
    Culebras, E
    Boloix, A
    Picazo, JJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) : 1838 - 1841
  • [7] Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbations of chronic bronchitis
    Cazzola, M
    Di Perna, F
    Boveri, B
    Di Marco, F
    Diamare, F
    Centanni, S
    [J]. JOURNAL OF CHEMOTHERAPY, 2000, 12 (03) : 216 - 222
  • [8] Craig W, 1998, HANDB EXP PHARM, V127, P207
  • [9] Pharmacokinetics and pharmacodynamics of antibiotics in otitis media
    Craig, WA
    Andes, D
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (03) : 255 - 259
  • [10] INTERRELATIONSHIP BETWEEN PHARMACOKINETICS AND PHARMACODYNAMICS IN DETERMINING DOSAGE REGIMENS FOR BROAD-SPECTRUM CEPHALOSPORINS
    CRAIG, WA
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 22 (1-2) : 89 - 96